stella
beta
Preoperative Neoadjuvant Immunotherapy Combined With Chemotherapy for Stage Ⅲ Unresectable Non-small Cell Lung Cancer — Stella
Recruiting
Back to Non-small-cell Lung Cancer (NSCLC) trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
China
the Affiliated Hospital of Qingdao University, Qingdao, Shandong
View full record on ClinicalTrials.gov